FDA Inspection
Osteolife Biomedical I LLCOsteolife Biomedical I LLC – FDA Inspection, Feb 13, 2026
Record Details
This FDA Inspection record concerns Osteolife Biomedical I LLC, with an inspection on February 13, 2026, issued by the Florida District Office, covering biologics.
View Company Profile
ID · cc42555d-bb87-4991-9795-ca2e6e41f2c6
Inspection Facts
- Inspection number
- 1302716
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.260(e)Periodic review of temperatures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Osteolife Biomedical I LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 14, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 4, 2022 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 28, 2018 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Osteolife Biomedical I LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.